X Pivot
oncology
Institut Universitaire des Sciences de lEducation
France
Biography
Department of Medical Oncology, University Hospital Jean Minjoz, Besançon xavier.pivot@univ-fcomte.fr.
Research Interest
oncology
Publications
-
Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study.
